Lion's Mane Mushroom

Lion's mane has an early but replicated signal for cognition, enough to be interesting, not enough to be confident. Mori 2009 (n=30, mild cognitive impairment) and Saitsu 2019 (n=31, healthy adults 50+) both found improved cognitive scores at 800-3,000mg/day for 12-16 weeks, and a newer double-blind RCT extended the signal to healthy younger adults. Mood data is preliminary. The bigger practical problem is product quality: most US lion's mane supplements use mycelium grown on grain, which tests at 35-70% alpha-glucan starch with as little as 1-2% beta-glucans, the bioactive compounds the clinical trials actually measured.

Two independent RCTs now support cognitive benefits. Mori et al. 2009 studied 30 elderly adults with mild cognitive impairment taking 3,000mg/day for 16 weeks - cognitive function improved significantly during supplementation but declined after stopping, suggesting the effects require ongoing use. Saitsu et al. 2019 (PMID: 31413233) studied 31 healthy adults aged 50+ taking 800mg/day for 12 weeks and found significant improvements on MMSE, Benton visual retention, and verbal paired-associate learning tests, with researchers attributing the effects to hericenones acting on brain neural networks. A separate double-blind RCT in healthy younger adults (PMC12018234) found acute cognitive and mood benefits, extending the signal beyond elderly populations.

For mood and anxiety, a small study of menopausal women found reductions in depression and anxiety scores over 4 weeks, along with improved concentration. These results are preliminary but plausible given serotonergic and hippocampal neurogenesis mechanisms.

The bioactive compounds are well-characterized: hericenones from the fruiting body and erinacines from the mycelium. Erinacine A crosses the blood-brain barrier, stimulates NGF synthesis, reduces amyloid plaque aggregation, and promotes neurogenesis. Erinacine S promotes axon regeneration via neurosteroid accumulation, even on inhibitory substrates that typically block CNS repair. In vitro laser microdissection axotomy models (PMID: 30570422) found H. erinaceus extract exceeded the regenerative activity of exogenous NGF alone - the combination maximized axonal regeneration capacity. Hericerin derivatives also activate ERK1/2 signaling in hippocampal neurons. Wong et al. 2012 demonstrated accelerated peripheral nerve regeneration via Akt/MAPK pathways with upregulation of c-Jun/c-Fos transcription factors. The preclinical mechanistic case is compelling but has no direct human RCT confirmation.

For gastrointestinal health, preclinical evidence is deep but human data sparse. H. erinaceus polysaccharides upregulate tight junction proteins ZO-1, ZO-2, and claudin-14 in intestinal epithelial cell lines. Rodent colitis models show NF-kB suppression and reduced inflammatory cytokines. A preliminary double-blind study (1985, n=25) showed symptomatic improvement in 63% of atrophic gastritis patients after 3 months. SCFAs generated by upregulated gut microbiota activate GPR41/GPR43 receptors on intestinal epithelial cells, linking the gut microbiome modulation to anti-inflammatory signaling. No RCTs exist for IBD or acute gastric conditions.

Product quality varies enormously. Pure fruiting body extracts typically contain 20-30%+ beta-glucans with less than 3% alpha-glucans (starch). Mycelium-on-grain products average 1-7% beta-glucans with 35-70% alpha-glucans (grain starch). Some MOG products test at 65% starch and less than 2% beta-glucans. Over 50% of mushroom supplements sold in the US use mycelium-on-grain. The "Total Polysaccharides" marketing claim is misleading because it conflates inert grain starch with bioactive fungal beta-glucans.